Equithrive Information

Equithrive® is the pioneer in equine resveratrol therapy. Equithrive® has developed a proprietary resveratrol product (Resverasyn®) that recently has been proven in multiple university studies to reduce lameness, inflammation and oxidative stress in performance horses. Excessive inflammation plays a major role in arthritis and in Equine Metabolic Syndrome (EMS). The company developed Equithrive® Joint to support healthy joint function in horses during aging, training and competition. Metabarol™ contains a higher dose of Resverasyn® and has been demonstrated to reduce insulin levels in EMS horses that are prone to foundering. Veterinarians across the United States now routinely prescribe Equithrive® Joint and Metabarol™ to support joint health and metabolic function in equine athletes and in older horses. Equithrive® is the global leader in Resveratrol therapy for horses.